Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about ESALF
Recent news which mentions ESALF
< Previous
1
2
Next >
Biogen/Eisai's Alzheimer's Drug Leqembi Gets 'No Go' From European Drug Regulator's Advisory Panel, Cites Serious Side Events
July 26, 2024
Tickers
BIIB
ESALF
ESALY
LLY
Tags
Large Cap
Biotech
BIIB
From
Benzinga
Bernie Sanders: 'Getting Sick In America Should Not Mean Going Bankrupt, Losing Your Home, Car, Or Life Savings'
July 15, 2024
Tickers
BIIB
BMY
ESALF
JNJ
Tags
Health Care
healthcare
BMY
From
Benzinga
Eli Lilly's Alzheimer's Therapy's Broad Label Reflects Regulatory Confidence in Anti-Amyloid Antibodies: Analyst
July 03, 2024
Tickers
BIIB
ESAIY
ESALF
LLY
Tags
Benzinga
LLY
Market News
From
Benzinga
Why Is Eli Lilly Stock Trading Higher Premarket Tuesday?
June 11, 2024
Tickers
BIIB
ESALF
LLY
NEWS
Tags
General
Briefs
why it's moving
From
Benzinga
European Medicines Agency Delays Approval Decision For Biogen-Eisai Partnered Alzheimer's Drug Lecanemab
March 22, 2024
Tickers
BIIB
ESALF
ESALY
NEWS
Tags
ESALF
Stories That Matter
General
From
Benzinga
Merck, Eisai Report Yet Another Failure For Keytruda Plus Lenvima Combo Trial, This Time In Endometrial Cancer
December 08, 2023
Tickers
ESALF
ESALY
MRK
Tags
ESALF
ESALY
News
From
Benzinga
Biogen quarterly results top estimates despite complex launch of new Alzheimer’s treatment
November 08, 2023
Tickers
BIIB
ESALF
SPX
Tags
SPX
ESALF
BIIB
From
MarketWatch
Eli Lilly chief scientific officer ‘extremely optimistic’ that major new Alzheimer’s breakthrough is coming
November 06, 2023
Tickers
BIIB
ESALF
JNJ
LLY
Tags
JNJ
ESALF
MRK
From
MarketWatch
Eli Lilly’s stock rises as results beat expectations, Mounjaro sales surge
November 02, 2023
Tickers
BIIB
ESALF
LLY
SPX
Tags
SPX
ESALF
BIIB
From
MarketWatch
Biogen and Eisai release new Alzheimer’s drug data that may support wider uptake
October 25, 2023
Tickers
BIIB
ESALF
LLY
Tags
ESALF
LLY
BIIB
From
MarketWatch
Improved Alzheimer's Diagnosis Access: CMS Expands Amyloid PET Scan Usage
October 13, 2023
Tickers
BIIB
ESALF
ESALY
LLY
Tags
General
Government
News
From
Benzinga
LuMind CEO At Odds With Neurologists Over Alzheimer's Drugs Made By Biogen, Eli Lilly
October 10, 2023
Tickers
BIIB
ESALF
ESALY
LLY
Tags
Benzinga
LLY
Market News
From
Benzinga
Amazon Invests $4B In ChatGPT Competitor, Hollywood Writers Accept Tentative Deal, ChatGPT Challenges Siri And Alexa With Introduction Of Verbal Responses: Today's Top Stories
September 25, 2023
Tickers
AA
AAPL
AMZN
BIIB
Tags
MBGAF
News
NVS
From
Benzinga
Japan's Regulatory Authority Approves Biogen/Eisai's Alzheimer Treatment Leqembi
September 25, 2023
Tickers
BIIB
ESALF
ESALY
Tags
BIIB
General
Health Care
From
Benzinga
Merck-Eisai Partnered Two Keytruda/Lenvima Combo Trials Flunk In Certain Types Of Lung Cancer
September 22, 2023
Tickers
ESALF
ESALY
MRK
Tags
General
ESALY
News
From
Benzinga
Merck/Eisai's Cancer Combo Therapy Ambition Dashed Once Again, Companies Throw Towel On Head & Neck Trial
August 25, 2023
Tickers
ESALF
ESALY
MRK
Tags
Large Cap
Biotech
Health Care
From
Benzinga
Quest Diagnostics launches first at-home blood test to assess risk of developing Alzheimer’s disease
July 31, 2023
Tickers
BIIB
DGX
ESALF
LLY
Tags
LLY
BIIB
DGX
From
MarketWatch
Biogen to slash 1,000 jobs as it looks to save $700 million
July 25, 2023
Tickers
BIIB
ESALF
LLY
SAGE
Tags
SPX
ESALF
LLY
From
MarketWatch
At-home Alzheimer’s testing is on the horizon, researchers say
July 19, 2023
Tickers
BIIB
ESALF
LLY
Tags
ESALF
BIIB
LLY
From
MarketWatch
Eli Lilly’s Alzheimer’s treatment shows promise in early stages of disease — but safety concerns remain
July 17, 2023
Tickers
BIIB
ESALF
LLY
SPX
Tags
ESALF
SPX
BIIB
From
MarketWatch
Expanded Medicare Coverage For Biogen-Eisai's Leqembi Signals a Turning Point in Alzheimer's Treatment: Analysts
July 07, 2023
Tickers
BIIB
ESALF
ESALY
Tags
ESALF
Analyst Color
Expert Ideas
From
Benzinga
Biogen’s big Alzheimer’s drug win fails to boost the stock as analysts see slow Leqembi rollout
July 07, 2023
Tickers
BIIB
ESALF
LLY
Tags
ESALF
BIIB
LLY
From
MarketWatch
FDA approves Alzheimer’s treatment Leqembi, clearing the way for Medicare coverage
July 06, 2023
Tickers
BIIB
ESALF
LLY
Tags
ESALF
LLY
BIIB
From
MarketWatch
Alzheimer's Drug Leqembi Faces Hurdles in Europe: Concerns Over Health Risks and Healthcare Resources
June 13, 2023
Tickers
BIIB
ESALF
ESALY
Tags
BIIB
Health Care
Biotech
From
Benzinga
Prospects for Full Approval of Eisai and Biogen's Leqembi Shine Brighter after FDA Committee Vote
June 12, 2023
Tickers
BIIB
ESALF
ESALY
Tags
Health Care
BIIB
Large Cap
From
Benzinga
Goldman pushes back against bearish Morgan Stanley’s Mike Wilson with new 4,500 S&P 500 target
June 12, 2023
Tickers
AAPL
AMC
AMD
AMZN
Tags
BX:TMUBMUSD02Y
MULN
DXY
From
MarketWatch
Biogen stock climbs on drug approval recommendation, Oracle shares rise ahead of earnings, and other stocks on the move
June 12, 2023
Tickers
BIIB
CCF
CVNA
ESALF
Tags
BIIB
CCF
CVNA
From
MarketWatch
FDA advisers vote in favor of Biogen and Eisai’s collaborative Alzheimer’s treatment
June 09, 2023
Tickers
BIIB
ESALF
Tags
ESALF
BIIB
From
MarketWatch
Bernie Sanders Takes on High Costs of Alzheimer's Treatment Leqembi, Calls Price Tag 'Unconscionable'
June 08, 2023
Tickers
BIIB
ESALF
ESALY
Tags
Benzinga
Alzheimer’s
Market News
From
Benzinga
FDA Signals Support for Eisai-Biogen Alzheimer's Drug Data Confirms Benefits For Complete Approval
June 08, 2023
Tickers
BIIB
ESALF
ESALY
Tags
Market News
Benzinga
FDA
From
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.